2021
2020
2019
2018
1
2
3
→
»
FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19
Dec 15, 2020
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 12, 2020
FSD Pharma Announces Settlement of Class Action Proceeding
Oct 29, 2020
FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering
Oct 21, 2020
FSD Pharma Inc. Announces US$9.5 Million Registered Direct Offering
Oct 16, 2020
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
Oct 5, 2020
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
Sep 28, 2020
FSD Pharma Announces Phase 2 Clinical Trial IND Filing With The FDA to Treat Patients With COVID-19
Aug 31, 2020